- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 69-83 of
1,261 results
No. 21
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 21 (N.D.W.Va. Apr. 29, 2022)
|
|
Cite Document
72 Motion Other: Novo Nordisk ASs Motion to Seal
Document
IPR2023-00724, No. 72 Motion Other - Novo Nordisk ASs Motion to Seal (P.T.A.B. Aug. 5, 2024)
|
|
Cite Document
70 Motion Other: Patent Owners Motion for Sanctions
Document
IPR2023-00724, No. 70 Motion Other - Patent Owners Motion for Sanctions (P.T.A.B. Jul. 31, 2024)
|
|
Cite Document
71 Motion Other: Patent Owners Motion for Additional Discovery
Document
IPR2023-00724, No. 71 Motion Other - Patent Owners Motion for Additional Discovery (P.T.A.B. Jul. 31, 2024)
|
|
Cite Document
No. 19
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 19 (N.D.W.Va. Apr. 8, 2022)
|
|
Cite Document
4 Motion Joinder: Motion for Joinder redacted
Document
IPR2024-00631, No. 4 Motion Joinder - Motion for Joinder redacted (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
3 Motion Other: Motion to Seal and Enter Protective Order
Document
IPR2024-00631, No. 3 Motion Other - Motion to Seal and Enter Protective Order (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
No. 12
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 12 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 10
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 10 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 9
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 9 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 11
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 11 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 2
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
24 Pet Reply to PO Resp: Redacted Patent Owners Reply to Petitioners Reply to Pa...
Document
IPR2024-00631, No. 24 Pet Reply to PO Resp - Redacted Patent Owners Reply to Petitioners Reply to Patent Owners Preliminary Response (P.T.A.B. Sep. 18, 2024)
|
|
Cite Document
51 Motion Other: Petitioners Motion to Seal
Document
IPR2023-00724, No. 51 Motion Other - Petitioners Motion to Seal (P.T.A.B. May. 22, 2024)
|
|
Cite Document
19 Other other: Apotexs Third Motion to Seal
Document
IPR2024-00631, No. 19 Other other - Apotexs Third Motion to Seal (P.T.A.B. Jul. 1, 2024)
|
|
Cite Document
